Maplight Therapeutics Inc (MPLT)

SG&A Expenses

$9.97M

Quarterly · Period ending: · USD

MPLT logo

MPLT SG&A Expenses

Latest reported$9.97M
MPLT Quarterly SG&A Expenses ($1.62M → $9.97M)
High-resolution chart · PNG

MPLT sg&a expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Maplight Therapeutics Inc SG&A Expenses — Quarterly (USD)
Period endingSG&A Expenses (USD)
9,966,000
10,657,000
18,754,000
4,404,000
3,817,000
3,756,000
2,064,000
4,080,000
4,343,000
3,944,000
1,617,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.